News Summary: Roche probed for not reporting side effects of cancer, other drugs
SERIOUS CHARGE: Europe’s top drug regulator is taking action against pharmaceutical giant Roche for allegedly failing to properly report the side effects of 19 drugs being used by U.S. patients. The regulator added there was no evidence that users of Roche’s drugs were at risk.
POTENTIAL PENALTY: If Roche is found to have violated its reporting requirements, it could be fined up to 5 per cent of its sales in the European Union from the preceding year.
RANGE OF TREATMENTS: Eight of the drugs involved are used for the treatment of cancer, including the blockbuster Avastin. The flu drug Tamiflu was also included in the list.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Leave a Reply
You must be logged in to post a comment.